Click Here to return To Results

 

Transdermal Rotigotine: Double-Blind, Placebo-Controlled Trial in Parkinson Disease Arch Neurol 64:676-682, Jankovic,J.,et al, 2007 See this aricle in Pubmed Article Abstract The rotigotine transdermal system consistently demonstrated statistically significant and clinically relevant efficacy over placebo in patients with early Parkinson disease and was well tolerated.

Related Tags

(click to filter results - removes previous filter) dopamine agonist Parkinson disease Parkinson disease,treatment of rotigotine transdermal medication treatment of neurologic disorder

Click Here to return To Results